首页 > 最新文献

General Thoracic and Cardiovascular Surgery最新文献

英文 中文
Physiological assessment of endoscopic mitral valve repair using cardiopulmonary exercise testing. 心肺运动试验对内窥镜二尖瓣修复的生理评价。
IF 1.3 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-08 DOI: 10.1007/s11748-025-02236-w
Takahiro Ozeki, Toshiaki Ito, Soh Hosoba, Ayumi Shintani, Mamoru Orii, Masayoshi Tokoro, Shinya Shimizu, Sadanari Sawaki, Akihiko Usui, Masato Mutsuga

Objectives: Few physiological assessments are available for patients who undergo mitral valve repair for severe mitral regurgitation (symptomatic or asymptomatic). The aim of the study was to evaluate change in exercise tolerance as a means of physiological assessment following mitral valve repair.

Methods: We studied 41 consecutive patients who received elective isolated mitral valve repair for severe mitral regurgitation in a minimally invasive manner via a completely endoscopic platform and who underwent cardiopulmonary exercise testing in our institution between February 2018 and August 2019. There were 21 asymptomatic (group A) and 20 symptomatic (group S) patients. Physiological assessment was performed by cycle ergometer cardiopulmonary exercise testing pre-operatively and at approximately 6 months post-operatively.

Results: Mean age was 59 ± 11.6 years and 24 patients were male (58.5%). Overall, there was no significant change in peak oxygen consumption or anaerobic threshold after surgical repair. There were no intergroup differences in terms of peak oxygen consumption, anaerobic threshold, ventilation/carbon dioxide production, or gas exchange ratio. There were no intergroup differences in any transthoracic echocardiographic variable except for post-operative left atrial dimension (group A: 35.2 ± 5.9 vs. group S: 39.8 ± 6.2, p = 0.01).

Conclusions: There was no statistically discernible change in functional capacity at 6-12 months after endoscopic mitral valve repair. The physiological assessment found no improvements in cardiopulmonary exercise testing values post-operatively despite improvement of the symptoms.

目的:对于严重二尖瓣返流(有症状或无症状)接受二尖瓣修复的患者,很少有生理学评估。这项研究的目的是评估运动耐受性的变化,作为二尖瓣修复后生理评估的一种手段。方法:我们研究了2018年2月至2019年8月在我院连续41例患者,这些患者通过完全内窥镜平台以微创方式接受选择性分离二尖瓣修复治疗严重二尖瓣反流,并进行了心肺运动试验。无症状患者21例(A组),有症状患者20例(S组)。术前和术后约6个月通过循环体能计心肺运动试验进行生理评估。结果:平均年龄59±11.6岁,男性24例(58.5%)。总的来说,手术修复后的峰值耗氧量或无氧阈值没有显著变化。在峰值耗氧量、厌氧阈值、通气量/二氧化碳产量或气体交换比方面,组间无差异。除术后左心房尺寸外,其他经胸超声心动图指标组间差异无统计学意义(A组:35.2±5.9 vs S组:39.8±6.2,p = 0.01)。结论:在内窥镜二尖瓣修复后6-12个月,功能能力没有统计学上可识别的变化。生理评估发现,尽管症状有所改善,但术后心肺运动测试值没有改善。
{"title":"Physiological assessment of endoscopic mitral valve repair using cardiopulmonary exercise testing.","authors":"Takahiro Ozeki, Toshiaki Ito, Soh Hosoba, Ayumi Shintani, Mamoru Orii, Masayoshi Tokoro, Shinya Shimizu, Sadanari Sawaki, Akihiko Usui, Masato Mutsuga","doi":"10.1007/s11748-025-02236-w","DOIUrl":"10.1007/s11748-025-02236-w","url":null,"abstract":"<p><strong>Objectives: </strong>Few physiological assessments are available for patients who undergo mitral valve repair for severe mitral regurgitation (symptomatic or asymptomatic). The aim of the study was to evaluate change in exercise tolerance as a means of physiological assessment following mitral valve repair.</p><p><strong>Methods: </strong>We studied 41 consecutive patients who received elective isolated mitral valve repair for severe mitral regurgitation in a minimally invasive manner via a completely endoscopic platform and who underwent cardiopulmonary exercise testing in our institution between February 2018 and August 2019. There were 21 asymptomatic (group A) and 20 symptomatic (group S) patients. Physiological assessment was performed by cycle ergometer cardiopulmonary exercise testing pre-operatively and at approximately 6 months post-operatively.</p><p><strong>Results: </strong>Mean age was 59 ± 11.6 years and 24 patients were male (58.5%). Overall, there was no significant change in peak oxygen consumption or anaerobic threshold after surgical repair. There were no intergroup differences in terms of peak oxygen consumption, anaerobic threshold, ventilation/carbon dioxide production, or gas exchange ratio. There were no intergroup differences in any transthoracic echocardiographic variable except for post-operative left atrial dimension (group A: 35.2 ± 5.9 vs. group S: 39.8 ± 6.2, p = 0.01).</p><p><strong>Conclusions: </strong>There was no statistically discernible change in functional capacity at 6-12 months after endoscopic mitral valve repair. The physiological assessment found no improvements in cardiopulmonary exercise testing values post-operatively despite improvement of the symptoms.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145700260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognosis for clinical early-stage lung cancer patients with subclinical malignant pleural effusion: Is anatomical resection a reasonable option? 临床早期肺癌合并亚临床恶性胸腔积液的预后:解剖切除是一个合理的选择吗?
IF 1.3 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-05 DOI: 10.1007/s11748-025-02235-x
Yoshitake Murata, Satoshi Iwasawa, Akihiro Matsuura, Yosuke Kumaya, Masakazu Yoshida, Ayuko Takahashi, Masashi Kobayashi

Objective: Non-small cell lung cancer with malignant pleural effusion is generally considered inoperable. The aim of this study was to investigate the prognosis and outcomes of patients with subclinical malignant pleural effusion who underwent surgical resection for lung cancer.

Methods: Between 2013 and 2022, 2261 patients underwent lung resections for non-small cell lung cancer. We retrospectively reviewed the records of 29 patients with cT1-2N0 lung cancer and subclinical malignant pleural effusion < 10 mL.

Results: The surgical procedures included wedge resection (n = 8) and anatomical resection (segmentectomy or lobectomy, n = 21). Fifteen patients underwent surgery + postoperative chemotherapy. During the follow-up period, 21 patients relapsed and 18 patients died. The median overall survival was 49 months, with a 3-year overall survival rate of 65.0%. The median progression-free survival was 14 months, with a 3-year progression-free survival rate of 20.1%. The 3-year overall survival rate was significantly higher for anatomical resection than for wedge resection (85.4% vs. 12.5%; P < 0.001). The 3-year progression-free survival rate was also significantly higher in the surgery + postoperative chemotherapy group than in the surgery-alone group (33.3% vs. 0%; P < 0.002).

Conclusion: Although the findings do not support surgery over conservative therapy, anatomical resection may be a reasonable option for patients with subclinical malignant pleural effusion.

目的:非小细胞肺癌合并恶性胸腔积液一般认为不宜手术治疗。本研究的目的是探讨亚临床恶性胸腔积液患者接受手术切除肺癌的预后和结局。方法:2013年至2022年间,2261例非小细胞肺癌患者接受了肺切除术。我们回顾性分析了29例cT1-2N0肺癌合并亚临床恶性胸腔积液患者的资料。结果:手术方式包括楔形切除(n = 8)和解剖切除(n = 21)。15例患者行手术+术后化疗。随访期间复发21例,死亡18例。中位总生存期为49个月,3年总生存率为65.0%。中位无进展生存期为14个月,3年无进展生存率为20.1%。解剖切除的3年总生存率明显高于楔形切除(85.4% vs. 12.5%)。结论:虽然研究结果不支持手术优于保守治疗,但解剖切除可能是亚临床恶性胸腔积液患者的合理选择。
{"title":"Prognosis for clinical early-stage lung cancer patients with subclinical malignant pleural effusion: Is anatomical resection a reasonable option?","authors":"Yoshitake Murata, Satoshi Iwasawa, Akihiro Matsuura, Yosuke Kumaya, Masakazu Yoshida, Ayuko Takahashi, Masashi Kobayashi","doi":"10.1007/s11748-025-02235-x","DOIUrl":"10.1007/s11748-025-02235-x","url":null,"abstract":"<p><strong>Objective: </strong>Non-small cell lung cancer with malignant pleural effusion is generally considered inoperable. The aim of this study was to investigate the prognosis and outcomes of patients with subclinical malignant pleural effusion who underwent surgical resection for lung cancer.</p><p><strong>Methods: </strong>Between 2013 and 2022, 2261 patients underwent lung resections for non-small cell lung cancer. We retrospectively reviewed the records of 29 patients with cT1-2N0 lung cancer and subclinical malignant pleural effusion < 10 mL.</p><p><strong>Results: </strong>The surgical procedures included wedge resection (n = 8) and anatomical resection (segmentectomy or lobectomy, n = 21). Fifteen patients underwent surgery + postoperative chemotherapy. During the follow-up period, 21 patients relapsed and 18 patients died. The median overall survival was 49 months, with a 3-year overall survival rate of 65.0%. The median progression-free survival was 14 months, with a 3-year progression-free survival rate of 20.1%. The 3-year overall survival rate was significantly higher for anatomical resection than for wedge resection (85.4% vs. 12.5%; P < 0.001). The 3-year progression-free survival rate was also significantly higher in the surgery + postoperative chemotherapy group than in the surgery-alone group (33.3% vs. 0%; P < 0.002).</p><p><strong>Conclusion: </strong>Although the findings do not support surgery over conservative therapy, anatomical resection may be a reasonable option for patients with subclinical malignant pleural effusion.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145677309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acknowledgment to reviewers. 感谢审稿人。
IF 1.3 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-04 DOI: 10.1007/s11748-025-02221-3
{"title":"Acknowledgment to reviewers.","authors":"","doi":"10.1007/s11748-025-02221-3","DOIUrl":"https://doi.org/10.1007/s11748-025-02221-3","url":null,"abstract":"","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145667900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stent part anastomosis reduces distal stent graft-induced new entry after frozen elephant trunk. 冷冻象鼻后支架部分吻合减少远端支架移植引起的新入腔。
IF 1.3 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-01 Epub Date: 2025-06-25 DOI: 10.1007/s11748-025-02175-6
Yoshinori Nakahara, Akira Marui, Tomohiro Iwakura, Takeyuki Kanemura

Objectives: Distal stent graft-induced new entry is a major complication after frozen elephant trunk procedure for type A acute aortic dissection. We investigated the impact of anastomosis location on this complication.

Methods: We reviewed 58 patients who underwent total arch replacement using frozen elephant trunk technique (2015-2023). Patients were divided by anastomosis location: Stent group (n = 24; anastomosis at stent part) and Fabric group (n = 34; anastomosis at graft part). We assessed early complications and mid-term distal aortic events during the follow-up.

Results: Patient characteristics were similar between groups. Early distal stent graft-induced new entry occurred in none of the Stent group versus 6 patients (18%) in the Fabric group (p = 0.04). Both groups showed similar false lumen thrombosis at arch and descending aorta. Freedom from distal aortic events at 1, 3, and 5 years was 100%, 81%, 81% (Stent group) versus 79%, 67%, 33% (Fabric group) (p = 0.049).

Conclusions: Anastomosis at the stent part during frozen elephant trunk procedure reduced distal stent graft-induced new entry and improved mid-term outcomes. In distal anastomosis, the fabric should be as short as possible.

目的:远端支架移植诱导的新血管进入是冷冻象鼻手术治疗a型急性主动脉夹层后的主要并发症。我们研究了吻合位置对该并发症的影响。方法:我们回顾了2015-2023年58例采用冷冻象鼻技术进行全弓置换术的患者。按吻合位置分组:支架组(n = 24);支架部分吻合)和织物组(n = 34;吻合于移植物部分)。我们在随访期间评估了早期并发症和中期主动脉远端事件。结果:两组患者特征相似。支架组未发生早期远端支架移植诱导的新入骨,而织物组有6例(18%)患者(p = 0.04)。两组在弓、降主动脉均有相似的假腔血栓形成。1年、3年和5年主动脉远端事件发生率分别为100%、81%、81%(支架组)和79%、67%、33%(支架组)(p = 0.049)。结论:冷冻象鼻手术中支架部分吻合减少了远端支架移植引起的新入腔,改善了中期预后。在远端吻合时,织物应尽可能短。
{"title":"Stent part anastomosis reduces distal stent graft-induced new entry after frozen elephant trunk.","authors":"Yoshinori Nakahara, Akira Marui, Tomohiro Iwakura, Takeyuki Kanemura","doi":"10.1007/s11748-025-02175-6","DOIUrl":"10.1007/s11748-025-02175-6","url":null,"abstract":"<p><strong>Objectives: </strong>Distal stent graft-induced new entry is a major complication after frozen elephant trunk procedure for type A acute aortic dissection. We investigated the impact of anastomosis location on this complication.</p><p><strong>Methods: </strong>We reviewed 58 patients who underwent total arch replacement using frozen elephant trunk technique (2015-2023). Patients were divided by anastomosis location: Stent group (n = 24; anastomosis at stent part) and Fabric group (n = 34; anastomosis at graft part). We assessed early complications and mid-term distal aortic events during the follow-up.</p><p><strong>Results: </strong>Patient characteristics were similar between groups. Early distal stent graft-induced new entry occurred in none of the Stent group versus 6 patients (18%) in the Fabric group (p = 0.04). Both groups showed similar false lumen thrombosis at arch and descending aorta. Freedom from distal aortic events at 1, 3, and 5 years was 100%, 81%, 81% (Stent group) versus 79%, 67%, 33% (Fabric group) (p = 0.049).</p><p><strong>Conclusions: </strong>Anastomosis at the stent part during frozen elephant trunk procedure reduced distal stent graft-induced new entry and improved mid-term outcomes. In distal anastomosis, the fabric should be as short as possible.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"911-918"},"PeriodicalIF":1.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144495718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends of aortic valve-preserving surgery in japan: an updated five-year nationwide survey. 日本主动脉瓣保留手术的趋势:一项最新的五年全国调查。
IF 1.3 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-01 Epub Date: 2025-06-15 DOI: 10.1007/s11748-025-02170-x
Satoshi Arimura, Takashi Kunihara, Yutaka Okita, Shuichiro Takanashi, Tatsuhiko Komiya, Hitoshi Yaku, Hitoshi Okabayashi, Hirofumi Takemura, Hirokuni Arai, Masaru Sawazaki, Yoshiro Matsui, Norihiko Shiiya

Objective: We evaluated trends and outcomes of aortic valve-preserving surgery (AVPS) in Japan, particularly with regard to aortic regurgitation (AR), in comparison with data from 2014.

Methods: We conducted a nationwide survey across 244 hospitals in Japan, focusing on aortic valve and aortic root surgeries performed in 2019. The breakdown of procedures, including isolated aortic valvuloplasty (AVP) and valve-sparing root replacement (VSRR), in AR patients was examined, and compared with the results from 2014.

Results: In 2019, the isolated AVP rate for AR was 5.5%, down from 7.5% in 2014. The VSRR rate among aortic root surgeries remained (33.1%). Within VSRR procedures, aortic valve reimplantation (reimplantation) accounted for 62.7% of cases, aortic root remodeling (remodeling) for 32.0%, and other root replacement techniques for 5.3%. AVPS was performed in 102 hospitals, with 10 institutions accounting for 42.2% of all cases. One-year reoperation rates for AVP, reimplantation, remodeling, and other root replacement were 8.0%, 1.8%, 6.0%, and 14.3%, respectively. Short-term (up to 4 years) aortic valve-related reoperation rates for AVP, reimplantation, and remodeling were 9.7%, 6.1%, and 9.5%, respectively. Use of a pericardial patch emerged as an independent risk factor for reoperation following AVPS (P = 0.022; odds ratio 3.382; 95% confidence interval 1.195-9.570).

Conclusions: The rate of AVP performed for AR in Japan decreased significantly from 2014 to 2019, while the rate of VSRR for root procedures remained stable. Use of a pericardial patch was identified as an independent risk factor for aortic valve-related reoperation following initial repair.

目的:我们评估了日本主动脉瓣保留手术(AVPS)的趋势和结果,特别是主动脉瓣反流(AR),并与2014年的数据进行了比较。方法:我们对日本244家医院进行了全国范围的调查,重点是2019年进行的主动脉瓣和主动脉根部手术。研究了AR患者的手术失败情况,包括孤立主动脉瓣成形术(AVP)和保留瓣膜的根置换术(VSRR),并与2014年的结果进行了比较。结果:2019年,AR的孤立AVP率为5.5%,低于2014年的7.5%。主动脉根部手术的VSRR率保持不变(33.1%)。在VSRR手术中,主动脉瓣再植(replantation)占62.7%,主动脉根重塑(remodeling)占32.0%,其他根置换技术占5.3%。102家医院实施了AVPS,其中10家机构占42.2%。AVP再手术率为8.0%,再植率为1.8%,重塑率为6.0%,其他根置换率为14.3%。AVP的短期(最多4年)主动脉瓣相关再手术率、再植入术率和重塑率分别为9.7%、6.1%和9.5%。心包贴片的使用是AVPS后再手术的独立危险因素(P = 0.022;优势比3.382;95%置信区间1.195-9.570)。结论:2014 - 2019年,日本AR的AVP率显著下降,而根管手术的VSRR率保持稳定。心包贴片的使用被认为是主动脉瓣初次修复后再次手术的独立危险因素。
{"title":"Trends of aortic valve-preserving surgery in japan: an updated five-year nationwide survey.","authors":"Satoshi Arimura, Takashi Kunihara, Yutaka Okita, Shuichiro Takanashi, Tatsuhiko Komiya, Hitoshi Yaku, Hitoshi Okabayashi, Hirofumi Takemura, Hirokuni Arai, Masaru Sawazaki, Yoshiro Matsui, Norihiko Shiiya","doi":"10.1007/s11748-025-02170-x","DOIUrl":"10.1007/s11748-025-02170-x","url":null,"abstract":"<p><strong>Objective: </strong>We evaluated trends and outcomes of aortic valve-preserving surgery (AVPS) in Japan, particularly with regard to aortic regurgitation (AR), in comparison with data from 2014.</p><p><strong>Methods: </strong>We conducted a nationwide survey across 244 hospitals in Japan, focusing on aortic valve and aortic root surgeries performed in 2019. The breakdown of procedures, including isolated aortic valvuloplasty (AVP) and valve-sparing root replacement (VSRR), in AR patients was examined, and compared with the results from 2014.</p><p><strong>Results: </strong>In 2019, the isolated AVP rate for AR was 5.5%, down from 7.5% in 2014. The VSRR rate among aortic root surgeries remained (33.1%). Within VSRR procedures, aortic valve reimplantation (reimplantation) accounted for 62.7% of cases, aortic root remodeling (remodeling) for 32.0%, and other root replacement techniques for 5.3%. AVPS was performed in 102 hospitals, with 10 institutions accounting for 42.2% of all cases. One-year reoperation rates for AVP, reimplantation, remodeling, and other root replacement were 8.0%, 1.8%, 6.0%, and 14.3%, respectively. Short-term (up to 4 years) aortic valve-related reoperation rates for AVP, reimplantation, and remodeling were 9.7%, 6.1%, and 9.5%, respectively. Use of a pericardial patch emerged as an independent risk factor for reoperation following AVPS (P = 0.022; odds ratio 3.382; 95% confidence interval 1.195-9.570).</p><p><strong>Conclusions: </strong>The rate of AVP performed for AR in Japan decreased significantly from 2014 to 2019, while the rate of VSRR for root procedures remained stable. Use of a pericardial patch was identified as an independent risk factor for aortic valve-related reoperation following initial repair.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"893-901"},"PeriodicalIF":1.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144301837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the advantages of minimally invasive coronary artery bypass grafting: the tip of the iceberg. 评价微创冠状动脉旁路移植术的优点:冰山一角。
IF 1.3 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-01 Epub Date: 2025-09-04 DOI: 10.1007/s11748-025-02197-0
Mesut Engin, Ahmet Burak Tatlı
{"title":"Evaluating the advantages of minimally invasive coronary artery bypass grafting: the tip of the iceberg.","authors":"Mesut Engin, Ahmet Burak Tatlı","doi":"10.1007/s11748-025-02197-0","DOIUrl":"10.1007/s11748-025-02197-0","url":null,"abstract":"","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"944-945"},"PeriodicalIF":1.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144992180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and internal validation of predictive models for spread through air spaces in clinical stage IA lung adenocarcinoma. 临床IA期肺腺癌通过空气空间扩散预测模型的发展和内部验证。
IF 1.3 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-01 Epub Date: 2025-04-28 DOI: 10.1007/s11748-025-02152-z
Guanghua Huang, Li Wang, Zhewei Zhao, Yadong Wang, Bowen Li, Zhicheng Huang, Xiaoqing Yu, Naixin Liang, Shanqing Li

Objective: Spread through air spaces (STAS) in lung adenocarcinoma impacted prognosis and treatment decisions, but lacked reliable preoperative prediction. We aimed to construct an easy-to-use model for clinical stage IA adenocarcinoma patients.

Methods: This study analyzed 1212 patients with clinical stage IA lung adenocarcinoma undergoing lung resections from November 2020 to January 2022. Two logistic regression models were developed. Model 1 used demographic and computed tomography features, and Model 2 incorporated maximum standardized uptake values additionally. Internal validation used tenfold cross-validation. Model discrimination and calibration were described by the area under the curve (AUC) and Spiegelhalter z test, respectively.

Results: Prevalence of STAS was 10.6%. Model 1 consisted of maximum tumor diameter, smoking history, location, spiculation and lobulation, showing moderate discrimination (AUC = 0.700). Model 2 consisted of smoking history, the maximum standardized uptake value, spiculation and lobulation, receiving an AUC of 0.807 and good calibration. Model 2 has a sensitivity and a specificity of 0.857 and 0.652. A nomogram for Model 2 was also developed.

Conclusion: Our study developed and validated two predictive models for STAS for clinical stage IA lung adenocarcinoma. Model 2, integrating maximum standardized uptake value, outperformed Model 1 and offered a more comprehensive approach to predicting STAS. Surgeon could consider the results of Model 2 and intraoperative frozen sections sequentially to optimize surgical strategies. External validation remained warranted.

目的:肺腺癌经空气间隙扩散(STAS)影响预后和治疗决策,但缺乏可靠的术前预测。我们的目标是建立一个易于使用的临床IA期腺癌患者模型。方法:本研究分析了2020年11月至2022年1月行肺切除术的1212例临床期IA期肺腺癌患者。开发了两个逻辑回归模型。模型1采用人口统计学和计算机断层扫描特征,模型2另外纳入了最大标准化摄取值。内部验证采用十倍交叉验证。模型判别和校正分别用曲线下面积(AUC)和Spiegelhalter z检验来描述。结果:STAS患病率为10.6%。模型1由最大肿瘤直径、吸烟史、位置、毛刺和分叶组成,具有中等判别性(AUC = 0.700)。模型2由吸烟史、最大标准化摄取值、毛泡和分叶组成,AUC为0.807,校准良好。模型2的敏感性为0.857,特异性为0.652。模型2的图也被开发出来。结论:我们的研究建立并验证了两种预测临床期肺腺癌STAS的模型。模型2整合了最大标准化吸收值,优于模型1,为预测STAS提供了更全面的方法。外科医生可以依次考虑模型2和术中冰冻切片的结果来优化手术策略。外部验证仍然是必要的。
{"title":"Development and internal validation of predictive models for spread through air spaces in clinical stage IA lung adenocarcinoma.","authors":"Guanghua Huang, Li Wang, Zhewei Zhao, Yadong Wang, Bowen Li, Zhicheng Huang, Xiaoqing Yu, Naixin Liang, Shanqing Li","doi":"10.1007/s11748-025-02152-z","DOIUrl":"10.1007/s11748-025-02152-z","url":null,"abstract":"<p><strong>Objective: </strong>Spread through air spaces (STAS) in lung adenocarcinoma impacted prognosis and treatment decisions, but lacked reliable preoperative prediction. We aimed to construct an easy-to-use model for clinical stage IA adenocarcinoma patients.</p><p><strong>Methods: </strong>This study analyzed 1212 patients with clinical stage IA lung adenocarcinoma undergoing lung resections from November 2020 to January 2022. Two logistic regression models were developed. Model 1 used demographic and computed tomography features, and Model 2 incorporated maximum standardized uptake values additionally. Internal validation used tenfold cross-validation. Model discrimination and calibration were described by the area under the curve (AUC) and Spiegelhalter z test, respectively.</p><p><strong>Results: </strong>Prevalence of STAS was 10.6%. Model 1 consisted of maximum tumor diameter, smoking history, location, spiculation and lobulation, showing moderate discrimination (AUC = 0.700). Model 2 consisted of smoking history, the maximum standardized uptake value, spiculation and lobulation, receiving an AUC of 0.807 and good calibration. Model 2 has a sensitivity and a specificity of 0.857 and 0.652. A nomogram for Model 2 was also developed.</p><p><strong>Conclusion: </strong>Our study developed and validated two predictive models for STAS for clinical stage IA lung adenocarcinoma. Model 2, integrating maximum standardized uptake value, outperformed Model 1 and offered a more comprehensive approach to predicting STAS. Surgeon could consider the results of Model 2 and intraoperative frozen sections sequentially to optimize surgical strategies. External validation remained warranted.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"919-925"},"PeriodicalIF":1.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143961377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Critical appraisal of claims-based analysis of reinterventions and medical costs after tetralogy of Fallot repair. 法洛四联症修复后再干预和医疗费用的基于索赔分析的批判性评估。
IF 1.3 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-01 Epub Date: 2025-09-04 DOI: 10.1007/s11748-025-02196-1
Minahil Laraib Asif, Idrees Shabbir, Neha Ather, Muhammad Ahsan
{"title":"Critical appraisal of claims-based analysis of reinterventions and medical costs after tetralogy of Fallot repair.","authors":"Minahil Laraib Asif, Idrees Shabbir, Neha Ather, Muhammad Ahsan","doi":"10.1007/s11748-025-02196-1","DOIUrl":"10.1007/s11748-025-02196-1","url":null,"abstract":"","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"942-943"},"PeriodicalIF":1.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144992268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reinterventions and medical costs after tetralogy of Fallot repair: a retrospective cohort study using health insurance claims in Japan. 法洛四联症修复后的再干预和医疗费用:日本健康保险索赔的回顾性队列研究。
IF 1.3 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-01 Epub Date: 2025-06-23 DOI: 10.1007/s11748-025-02174-7
Yasutaka Hirata, Shintaro Nemoto, Yusei Hamada, Akihiro Nakajima, Yasumi Nishiwaki, Kosuke Kikuchi

Background: Reinterventions after congenital heart disease surgery include not only reoperations but also medical catheter interventions, and the details of these treatment realities are often unclear. This study aimed to elucidate the medical and surgical reinterventions and associated medical costs after the tetralogy of Fallot (TOF) repair using Japanese health insurance claims data.

Methods and results: We analyzed reinterventions and medical costs from insurance claims data of patients who underwent TOF repair between 2005 and 2021. Of 174 patients who underwent TOF repair, 23 (13.2%) received a total of 34 reinterventions. These included 23 percutaneous catheter interventions and 11 reoperations. The 5-year reintervention-free rate was 87.5% overall, 94.9% for surgeries with right ventricular outflow tract reconstruction (N = 130), and 65.6% for surgeries with peripheral pulmonary artery plasty (N = 44). The median (interquartile range) medical cost for patients without reintervention was ¥5.33 million (4.62-7.14 million) and the cost for the patients with reintervention was ¥ 10.59 million (7.73-13.97 million).

Conclusion: Using Japanese insurance claims data, we analyzed the reoperation and catheter intervention after the TOF repair. The reintervention-free rate after TOF repair differed significantly by surgical procedure with a tendency for poorer postoperative prognosis, particularly in cases involving the peripheral pulmonary artery plasty. These analysis results may contribute to predicting outcomes after TOF repair for healthcare professionals.

背景:先天性心脏病手术后的再干预不仅包括再手术,还包括医疗导管干预,这些治疗现实的细节往往不清楚。本研究旨在利用日本健康保险理赔资料,阐明法洛四联症(TOF)修复后的医疗和手术再干预及相关医疗费用。方法和结果:我们从2005年至2021年接受TOF修复的患者的保险索赔数据中分析再干预和医疗费用。174例接受TOF修复的患者中,23例(13.2%)总共接受了34次再干预。其中包括23例经皮导管介入治疗和11例再手术。5年无再干预率总体为87.5%,右室流出道重建手术为94.9% (N = 130),肺动脉周围动脉成形术为65.6% (N = 44)。无再干预患者的医疗费用中位数(四分位差)为533万元(462 ~ 714万),有再干预患者的医疗费用中位数为1059万元(773 ~ 1397万)。结论:利用日本保险理赔资料,分析了TOF修复后的再手术和导管介入情况。TOF修复后的无再干预率因手术方式而有显著差异,且术后预后倾向较差,特别是涉及肺动脉外周成形术的病例。这些分析结果可能有助于医疗保健专业人员预测TOF修复后的结果。
{"title":"Reinterventions and medical costs after tetralogy of Fallot repair: a retrospective cohort study using health insurance claims in Japan.","authors":"Yasutaka Hirata, Shintaro Nemoto, Yusei Hamada, Akihiro Nakajima, Yasumi Nishiwaki, Kosuke Kikuchi","doi":"10.1007/s11748-025-02174-7","DOIUrl":"10.1007/s11748-025-02174-7","url":null,"abstract":"<p><strong>Background: </strong>Reinterventions after congenital heart disease surgery include not only reoperations but also medical catheter interventions, and the details of these treatment realities are often unclear. This study aimed to elucidate the medical and surgical reinterventions and associated medical costs after the tetralogy of Fallot (TOF) repair using Japanese health insurance claims data.</p><p><strong>Methods and results: </strong>We analyzed reinterventions and medical costs from insurance claims data of patients who underwent TOF repair between 2005 and 2021. Of 174 patients who underwent TOF repair, 23 (13.2%) received a total of 34 reinterventions. These included 23 percutaneous catheter interventions and 11 reoperations. The 5-year reintervention-free rate was 87.5% overall, 94.9% for surgeries with right ventricular outflow tract reconstruction (N = 130), and 65.6% for surgeries with peripheral pulmonary artery plasty (N = 44). The median (interquartile range) medical cost for patients without reintervention was ¥5.33 million (4.62-7.14 million) and the cost for the patients with reintervention was ¥ 10.59 million (7.73-13.97 million).</p><p><strong>Conclusion: </strong>Using Japanese insurance claims data, we analyzed the reoperation and catheter intervention after the TOF repair. The reintervention-free rate after TOF repair differed significantly by surgical procedure with a tendency for poorer postoperative prognosis, particularly in cases involving the peripheral pulmonary artery plasty. These analysis results may contribute to predicting outcomes after TOF repair for healthcare professionals.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"902-910"},"PeriodicalIF":1.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12681453/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144474820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mid-term results of the floating stitch for systolic anterior motion in hypertrophic obstructive cardiomyopathy. 浮动针对肥厚性梗阻性心肌病收缩期前运动的中期评价。
IF 1.3 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-12-01 Epub Date: 2025-06-12 DOI: 10.1007/s11748-025-02167-6
Tomonari Uemura, Akihiko Usui, Yoshiyuki Tokuda, Yuji Narita, Masato Mutsuga

Objective: Systolic anterior motion (SAM) is an important factor for hypertrophic obstructive cardiomyopathy (HOCM) patients with a hypertrophic interventricular septum. We developed the 'floating stitch technique' to relieve SAM and have used it since 2017. The mid-term results of the floating stitch technique are reported.

Methods: Ten consecutive HOCM patients (5 male, mean age 65.6 years) who underwent septal myectomy and the floating stitch technique from 2017 to 2022 were included. All patients underwent preoperative, pre-discharge, and annual follow-up echocardiographic evaluations. The median postoperative observation period was 3.5 (range 1.2-6.6) years.

Results: There were no cases of cutting or elongation of the floating stitch during the follow-up period. The median mitral valve area (MVA) was 2.9 [interquartile range (IQR) 2.6-3.1] cm2 before surgery, 2.6 (IQR 2.2-2.7) cm2 before discharge, and 2.6 (IQR 2.2-2.8) cm2 at the latest follow-up. There were no cases of mitral stenosis clinically. All cases showed a significant decrease in the left ventricular outflow tract pressure gradient after surgery, but one case required re-operation due to recurrent obstruction at the mid-cardiac position. SAM did not recur in any cases, and all patients were in NYHA class 1 at the latest follow-up.

Conclusions: The floating stitch technique showed an excellent SAM-suppression effect and durability. MVA decreased about 10% following the floating stitch technique, but sufficient area was secured without functional mitral stenosis. The combination of septal myectomy and floating stitch technique is a simple and reproducible procedure for HOCM, especially with severe SAM.

目的:收缩期前运动(SAM)是肥厚性阻塞性心肌病(HOCM)合并室间隔肥厚的重要因素。我们开发了“浮针技术”来缓解SAM,并从2017年开始使用。报道了浮针技术的中期成果。方法:选取2017年至2022年连续行鼻中隔肌切除术和漂浮针术的10例HOCM患者(男性5例,平均年龄65.6岁)。所有患者均接受术前、出院前和年度随访超声心动图评估。术后中位观察期为3.5年(1.2-6.6年)。结果:随访期间无浮针剪断、延长病例。术前二尖瓣中位面积(MVA)为2.9[四分位间距(IQR) 2.6-3.1] cm2,出院前为2.6 (IQR 2.2-2.7) cm2,最新随访时为2.6 (IQR 2.2-2.8) cm2。临床无二尖瓣狭窄病例。所有病例术后左心室流出道压力梯度均明显下降,但1例因心中位反复梗阻需再次手术。所有病例均未复发,最新随访时均为NYHA 1级。结论:浮针技术具有良好的抑制sam的效果和耐久性。浮动针技术使MVA降低了约10%,但确保了足够的面积,无功能性二尖瓣狭窄。中隔肌切除术和浮动针技术的结合是HOCM的一种简单和可重复性的手术,特别是严重的SAM。
{"title":"Mid-term results of the floating stitch for systolic anterior motion in hypertrophic obstructive cardiomyopathy.","authors":"Tomonari Uemura, Akihiko Usui, Yoshiyuki Tokuda, Yuji Narita, Masato Mutsuga","doi":"10.1007/s11748-025-02167-6","DOIUrl":"10.1007/s11748-025-02167-6","url":null,"abstract":"<p><strong>Objective: </strong>Systolic anterior motion (SAM) is an important factor for hypertrophic obstructive cardiomyopathy (HOCM) patients with a hypertrophic interventricular septum. We developed the 'floating stitch technique' to relieve SAM and have used it since 2017. The mid-term results of the floating stitch technique are reported.</p><p><strong>Methods: </strong>Ten consecutive HOCM patients (5 male, mean age 65.6 years) who underwent septal myectomy and the floating stitch technique from 2017 to 2022 were included. All patients underwent preoperative, pre-discharge, and annual follow-up echocardiographic evaluations. The median postoperative observation period was 3.5 (range 1.2-6.6) years.</p><p><strong>Results: </strong>There were no cases of cutting or elongation of the floating stitch during the follow-up period. The median mitral valve area (MVA) was 2.9 [interquartile range (IQR) 2.6-3.1] cm<sup>2</sup> before surgery, 2.6 (IQR 2.2-2.7) cm<sup>2</sup> before discharge, and 2.6 (IQR 2.2-2.8) cm<sup>2</sup> at the latest follow-up. There were no cases of mitral stenosis clinically. All cases showed a significant decrease in the left ventricular outflow tract pressure gradient after surgery, but one case required re-operation due to recurrent obstruction at the mid-cardiac position. SAM did not recur in any cases, and all patients were in NYHA class 1 at the latest follow-up.</p><p><strong>Conclusions: </strong>The floating stitch technique showed an excellent SAM-suppression effect and durability. MVA decreased about 10% following the floating stitch technique, but sufficient area was secured without functional mitral stenosis. The combination of septal myectomy and floating stitch technique is a simple and reproducible procedure for HOCM, especially with severe SAM.</p>","PeriodicalId":12585,"journal":{"name":"General Thoracic and Cardiovascular Surgery","volume":" ","pages":"885-892"},"PeriodicalIF":1.3,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12681494/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144283531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
General Thoracic and Cardiovascular Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1